Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

OneWater Marine Navigates Choppy Financial Waters

Dieter Jaworski by Dieter Jaworski
September 19, 2025
in Analysis, Consumer & Luxury, Insider Trading, Trading & Momentum
0
Onewater Marine Stock
0
SHARES
135
VIEWS
Share on FacebookShare on Twitter

The recreational boating retailer OneWater Marine faces mounting headwinds in a challenging market. As the company revises its financial forecasts downward, technical indicators and a wave of insider selling point to growing pessimism on Wall Street.

Insider Transactions Raise Concerns

A clear signal of internal sentiment has emerged from recent trading activity. Corporate insiders have been exclusively selling shares over the past three months, with no reported purchases. Director John Troiano disposed of more than 15,000 shares in late August. In a more significant move, Director Jeffrey B. Lamkin sold Class A shares worth over one million dollars. This consistent selling by those with the deepest knowledge of the company’s prospects casts doubt on internal confidence.

Quarterly Results Trigger Guidance Slash

The company’s recent third-quarter fiscal 2025 financial report illustrates the source of this caution. Revenue saw a modest increase of 1.9%, reaching $552.9 million. However, profitability came under significant pressure. Gross profit declined to $128.7 million, with the corresponding margin contracting by 110 basis points. The most dramatic drop was in net income, which fell nearly 36% from $16.7 million to $10.7 million.

Should investors sell immediately? Or is it worth buying Onewater Marine?

In response to these difficult results, management issued a severe reduction in its full-year outlook. OneWater Marine now anticipates adjusted earnings per share for fiscal 2025 to be in the range of $0.50 to $0.75, a stark downward revision from its previous forecast of $2.50 to $3.00.

Technical Picture Points to Further Weakness

The stock’s chart analysis reinforces the negative fundamental outlook. Key technical indicators are flashing sell signals. Both short-term and long-term moving averages are suggesting downward momentum, while the 3-month MACD indicator is actively signaling a sell—a classic technical sign of weakening price action. The share price appears to be facing formidable resistance at the $16.15 and $16.34 levels. Meanwhile, critical support levels at $15.21 and $14.57 are now under threat.

This bearish perspective is shared by a substantial portion of the market, as evidenced by a notably high short interest of over 24%. This indicates a strong consensus among traders that the stock’s value is likely to decline further in the near term.

Ad

Onewater Marine Stock: Buy or Sell?! New Onewater Marine Analysis from February 7 delivers the answer:

The latest Onewater Marine figures speak for themselves: Urgent action needed for Onewater Marine investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Onewater Marine: Buy or sell? Read more here...

Tags: Onewater Marine
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
AeroVironment Stock

AeroVironment Stock Soars on Strategic Wins and Strong Fundamentals

Alkami Technology Stock

Alkami Technology: The Digital Banking Innovator Gaining Market Confidence

Winmark Stock

Insider Selling and Lofty Valuations Raise Questions for Winmark Stock

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com